Literature DB >> 304697

[Localization of enolases 1 and 2 on chromosomes 1 and 12 respectively by the analysis of human-mouse hybrids].

N Van-Cong, D Weil, R Rebourcet, J Frézal.   

Abstract

The study of enolase in man-mouse somatic hybrids confirms synteny between ENO1 and the markers on human chromosome 1 (AK2, PGM1, Pep-C) and synteny between ENO2 and the markers on human chromosome 12 (LDHB, Pep-B). The study also shows that the different enolase bands observed in mouse cell strains (Cl1D, R4, A9, 3T3), in hamster cell strains (CH, V79/4, A3), and in 3 of the different bands observed in human fibroblasts have a dimeric structure. The formation of these enolase bands depends on genes at two different loci alpha and beta. The hamster cell line CH (HGPRT) showed a rare enolase phenotype with a two-banded pattern in the intermediate region, a triple-banded pattern in the slow region, and one single isozyme in the fast region. This hamster strain is heterozygous for the first locus and homozygous for the second one. The relationship between these different enolase bands is as follow: in the slow "a" zone, alpha1alpha1,alpha1 alpha2,alpha2alpha2; in the intermediate "i" zone, alpha1beta1, alpha2beta1; and, in the fast "b" zone, beta1beta1. It appears that the frequency of heterozygotes for the alpha or beta loci in man is very low. Of 32 unrelated fibroblast strains investigated, none was found to be heterozygous for the alpha or beta locus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 304697

Source DB:  PubMed          Journal:  Ann Genet        ISSN: 0003-3995


  2 in total

1.  [Regional localization of the genes for human LDHb, TPI, ENO2, PepB, PGK, alphaGALa, HGPRT, G6PD by interspecific hybridization (author's transl)].

Authors:  D Weil; N Van-Cong; R Rebourcet; J Frézal
Journal:  Hum Genet       Date:  1978-06-09       Impact factor: 4.132

2.  Gene mapping of the gibbon. Its position in primate evolution.

Authors:  C Turleau; N Créau-Goldberg; C Cochet; J de Grouchy
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.